vimarsana.com
Home
Live Updates
ABIONYX Pharma Reports Positive Results from Phase 2a Pilot Clinical Trial Evaluating CER-001 in the Treatment of Septic Patients at High Risk of Developing Acute Kidney Injury : comparemela.com
ABIONYX Pharma Reports Positive Results from Phase 2a Pilot Clinical Trial Evaluating CER-001 in the Treatment of Septic Patients at High Risk of Developing Acute Kidney Injury
Positive results on primary and secondary endpoints, identifying dose for future development Direct and significant effect of CER-001 on endotoxin removal and consequent reduction in the inflammatory
Related Keywords
Bari ,
Puglia ,
Italy ,
Italian ,
Loreto Gesualdo ,
Antonio Crovace ,
Nicolas Fossiez ,
Connie Peyrottes ,
Arthur Rouill ,
Louis Victor Delouvrier ,
Michael Davidson ,
Salvatore Grasso ,
University Of Bari Aldo Moro ,
University Of Bari ,
Acute Kidney Injury ,
Transplantation Unit ,
Bari Aldo Moro ,
Kidney Disease ,
Improving Global Outcomes ,
High Density Lipoprotein ,
Scientific Advisory Board ,
Temporary Authorization ,
Named Use ,
Italian Veterinarian Hospital ,
Surgical Section ,
Resuscitation Unit ,
Sequential Organ Failure Assessment ,
Intensive Care ,
Victor Delouvrier ,
Abionyx ,
Dharma ,
Reports ,
Positive ,
Results ,
Rom ,
Hase ,
Pilot ,
Linical ,
Trial ,
Valuating ,
Treatment ,
Septic ,
Patients ,
Thigh ,
Risk ,
Developing ,
Cute ,
Kidney ,
Injury ,
comparemela.com © 2020. All Rights Reserved.